跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
LANEIGE HYDRO UV DEFENSE
Authorized
STANDARD
LANEIGE HYDRO UV DEFENSE
AMOREPACIFIC CORPORATION
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
64790f91fd606c60
Company
AMOREPACIFIC CORPORATION
Type
Standard
Approval Details
Approval Id
64790f91fd606c60
Drug Approval Canada Name
LANEIGE HYDRO UV DEFENSE
Product Name
LANEIGE HYDRO UV DEFENSE
Status
Cancelled Post Market
Status Date
2023-12-16
Original Market Date
2021-11-12
Din
02518368
Drug Class
Human
Dosage Form
Cream
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:80.00
Atc Original
D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name
d 02 ba 30
Aig Number
0451521063
Company Name
AMOREPACIFIC CORPORATION
Company Address
100 Hangang-Daero, Yongsan-Gu, Seoul, Seoul National Capital Area, Korea, Republic Of, 04386
Company Detail Path
/organization/amorepacific-corporation
Company Information
Pharmaceutical Company Name
AMOREPACIFIC CORPORATION
Country Name
South Korea
Province Name
gyeonggi,country_kr
City Name
osan,gyeonggi,country_kr
Address
37 Gajangsaneopdong-ro
Website
http://eng.amorepacific.co.kr/
Active Ingredients
AVOBENZONE
2.5 % / W/W
HOMOSALATE
9 % / W/W
OCTISALATE
4.5 % / W/W
OCTOCRYLENE
9 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
64790f91fd606c60
Type
Standard
Back to Health Canada Approvals
LANEIGE HYDRO UV DEFENSE - Health Canada Drug Approval Details